Enzyme | Accession No. | Peptide Sequence | MRM (Parent/Transition) |
---|---|---|---|
1A2 | NP_034123.1 | T254FNDNFVLFLQK265 | 743.390/747.476 (y6) |
TFNDNFVLFLQK* | 747.398/755.491 (y6) | ||
2A12 | NP_598418.1 | E88ALVDHAEEFSGR100 | 730.344/1047.449 (y9) |
2B9 | NP_034130.1 | D263YIDTYLLR271 | 586.303/780.425 (y6) |
2B10 | NP_034129.1 | G99TVAVVEPTFK109 | 574.322/819.461 (y7) |
GTVAVVEPTFK* | 578.329/827.475 (y7) | ||
2C29 | NP_031841.3 | N49ISQSFTNFSK59 | 636.815/830.404 (y7) |
2C37 | NP_034131.2 | Y308AILLLLK315 | 473.820/712.533 (y6) |
2C39 | NP_034133.2 | F126TLTTLR132 | 426.253/603.382 (y5) |
2C50 | NP_598905.2 | G384TNVITSLSSVLR396 | 673.886/862.499 (y8) |
2C54 | NP_996260.1 | E85ALVDHGDVFAGR97 | 693.344/973.449 (y9) |
2C67 | NP_001019890.1 | V125FTINTLR132 | 482.285/503.294 (y4) |
2C70 | NP_663474.2 | E85ALIDQGDEFSDK97 | 733.836/1040.417 (y9) |
2D9 | NP_034136.2 | D408ESVWEKPLR417 | 629.825/828.473 (y6) |
2D10 | NP_034135.2 | F369GDIAPLNLPR379 | 606.840/709.436 (y6) |
2D22 | NP_062797.3 | T263TWDPTQPPR272 | 599.796/695.383 (y6) |
TTWDPTQPPR* | 604.800/705.392 (y6) | ||
2D26 | NP_083838.1 | G121VILAPYGPEWR132 | 679.367/454.302 (b5) |
2E1 | NP_067257.1 | G113IIFNNGPTWK123 | 623.833/963.468 (y8) |
2F2 | NP_031843.2 | S48QDLLTSLTK57 | 553.309/662.408 (y6) |
2J5 | NP_034137.1 | L50PFVGNFFQIDTK62 | 763.406/1012.510 (y8) |
2U1 | NP_082092.2 | E464TFIPFGIGK473 | 554.805/618.361 (y6) |
3A11 | NP_031844.1 | L332QDEIDEALPNK343 | 692.851/358.208 (y3) |
LQDEIDEALPNK* | 696.858/366.223 (y3) | ||
3A13 | NP_031845.1 | D244VISFFTTSVER255 | 700.856/839.426 (y7) |
3A25 | NP_062766.2 | F447ALISIK453 | 396.255/573.397 (y5) |
4A10 | NP_034141.3 | T215YLQAIGDLNNLFHSR230 | 621.323/887.448 (y7) |
4A12A | NP_803125.2 | S214YIQAVEDLNDLVFSR229 | 934.973/1207.595 (y10) |
4B1 | NP_031849.1 | G125LLVLEGPK133 | 463.289/642.382 (y6) |
4F13 | NP_570952.1 | S453PLAFIPFSAGTR465 | 682.372/735.378 (y7) |
4V2 | NP_598730.1 | V391FPSVPLFAR400 | 566.829/886.515 (y8) |
VFPSVPLFAR* | 571.833/896.523 (y8) |
* designating the last letter only, which is intended to indicate the only heavy labeled residue of the entire boldface peptide sequence.